Rapid assembly of functional modules for generating human artificial chromosome constructs compatible with epigenetic
Gabriel J Birchak1,2,3,4, Daniel G Gibson5, Praveen Kumar Allu1,2,3
1Department of Biochemistry & Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
Summary
Researchers developed a new method for building human artificial chromosomes (HACs) using bacterial artificial chromosomes (BACs) and yeast artificial chromosomes (YACs). This efficient approach simplifies the creation and validation of complex HAC constructs for genetic delivery.
Area of Science:
- Genetics
- Molecular Biology
- Synthetic Biology
Background:
- Human artificial chromosomes (HACs) are crucial for studying centromere function and delivering large genetic payloads.
- Previous HAC development faced challenges like multimerization and complex assembly using yeast artificial chromosomes (YACs).
Purpose of the Study:
- To develop a more efficient and streamlined method for constructing multi-module HACs.
- To facilitate the rapid assembly and validation of HACs for diverse applications.
Main Methods:
- Utilized high-fidelity in vitro assembly in bacterial artificial chromosomes (BACs) for module construction.
- Employed a simplified transformation-associated recombination (TAR) step to transfer BAC modules into a YAC.
- Leveraged Oxford Nanopore Technologies (ONT) sequencing for rapid clone validation and de novo assembly.
Main Results:
- Achieved high efficiency, with two-thirds of screened yeast clones containing the correct TAR product.
- Successfully constructed and validated a multi-module HAC using the developed approach.
- Demonstrated the formation of functional HACs in human cells post-fusion.
Conclusions:
- The novel BAC-to-YAC assembly strategy significantly enhances the efficiency of multi-module HAC construction.
- This method enables rapid engineering of HACs with specific design features and diverse genetic cargoes.
- The streamlined validation process accelerates the development of HACs for genetic research and therapeutic applications.


